Cargando…
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Breast cancer, specifically metastatic breast, is a leading cause of morbidity and mortality in women. This is mainly due to relapse and reoccurrence of tumor. The primary reason for cancer relapse is the development of multidrug resistance (MDR) hampering the treatment and prognosis. MDR can occur...
Autores principales: | Gote, Vrinda, Nookala, Anantha Ram, Bolla, Pradeep Kumar, Pal, Dhananjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125767/ https://www.ncbi.nlm.nih.gov/pubmed/33925129 http://dx.doi.org/10.3390/ijms22094673 |
Ejemplares similares
-
Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells
por: Gote, Vrinda, et al.
Publicado: (2021) -
Octreotide-Targeted Lcn2 siRNA PEGylated Liposomes as a Treatment for Metastatic Breast Cancer
por: Gote, Vrinda, et al.
Publicado: (2021) -
Self-Assembling Tacrolimus Nanomicelles for Retinal Drug Delivery
por: Gote, Vrinda, et al.
Publicado: (2020) -
Lutein-Loaded, Biotin-Decorated Polymeric Nanoparticles Enhance Lutein Uptake in Retinal Cells
por: Bolla, Pradeep Kumar, et al.
Publicado: (2020) -
Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes
por: Nookala, Anantha Ram, et al.
Publicado: (2014)